Free Trial

National Vision (NASDAQ:EYE) Reaches New 12-Month Low - Should You Sell?

National Vision logo with Medical background

National Vision Holdings, Inc. (NASDAQ:EYE - Get Free Report) reached a new 52-week low on Tuesday . The company traded as low as $9.56 and last traded at $9.60, with a volume of 115807 shares traded. The stock had previously closed at $9.85.

Analyst Upgrades and Downgrades

Several research firms have recently commented on EYE. The Goldman Sachs Group lowered their target price on shares of National Vision from $20.00 to $13.00 and set a "neutral" rating on the stock in a report on Friday, August 9th. Barclays reduced their price objective on National Vision from $16.00 to $11.00 and set an "equal weight" rating on the stock in a research note on Thursday, August 8th. Finally, UBS Group lowered their target price on National Vision from $20.00 to $18.00 and set a "buy" rating for the company in a research report on Thursday, August 8th. Three analysts have rated the stock with a hold rating and one has assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus target price of $15.25.

Get Our Latest Analysis on EYE

National Vision Stock Down 1.7 %

The company has a debt-to-equity ratio of 0.17, a current ratio of 0.55 and a quick ratio of 0.41. The company has a 50-day simple moving average of $10.43 and a 200-day simple moving average of $13.29. The firm has a market cap of $760.47 million, a PE ratio of -10.52, a price-to-earnings-growth ratio of 1.99 and a beta of 1.41.

National Vision (NASDAQ:EYE - Get Free Report) last announced its quarterly earnings data on Wednesday, August 7th. The company reported $0.15 earnings per share for the quarter, beating analysts' consensus estimates of $0.09 by $0.06. The company had revenue of $451.70 million during the quarter, compared to analyst estimates of $451.35 million. National Vision had a negative net margin of 4.00% and a positive return on equity of 3.53%. The firm's revenue for the quarter was down 14.0% on a year-over-year basis. During the same quarter last year, the business posted $0.11 EPS. Analysts expect that National Vision Holdings, Inc. will post 0.26 earnings per share for the current fiscal year.

Institutional Trading of National Vision

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. CWM LLC lifted its holdings in shares of National Vision by 44.8% during the 2nd quarter. CWM LLC now owns 2,717 shares of the company's stock valued at $36,000 after purchasing an additional 841 shares during the last quarter. ProShare Advisors LLC boosted its holdings in National Vision by 7.4% in the first quarter. ProShare Advisors LLC now owns 15,674 shares of the company's stock worth $347,000 after acquiring an additional 1,076 shares in the last quarter. Texas Permanent School Fund Corp grew its stake in shares of National Vision by 1.7% during the first quarter. Texas Permanent School Fund Corp now owns 68,480 shares of the company's stock worth $1,518,000 after acquiring an additional 1,117 shares during the last quarter. Linden Thomas Advisory Services LLC increased its holdings in shares of National Vision by 10.0% during the second quarter. Linden Thomas Advisory Services LLC now owns 20,176 shares of the company's stock valued at $264,000 after acquiring an additional 1,832 shares in the last quarter. Finally, Innealta Capital LLC acquired a new position in shares of National Vision during the second quarter valued at about $30,000.

National Vision Company Profile

(Get Free Report)

National Vision Holdings, Inc, through its subsidiaries, operates as an optical retailer in the United States. The company operates in two segments, Owned & Host and Legacy. It offers eyeglasses and contact lenses, and optical accessory products; provides eye exams through its America's Best, Eyeglass World, Vista Optical, Fred Meyer, and Vista Optical military, as well as Vision Center branded stores; and offers health maintenance organization and optometric services.

Recommended Stories

Should you invest $1,000 in National Vision right now?

Before you consider National Vision, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and National Vision wasn't on the list.

While National Vision currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Why Whitestone REIT is Outperforming in 2024: 35% Growth & Monthly Dividends
Why SoundHound Stock Dip Could Mean Big Gains for 2025 Investors
Nintendo Stock: Buy Before the 2025 Switch Platform Hits!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines